BrainsWay Ltd. BWAY
Company Profile ↓Company Overview
BrainsWay Ltd. (BWAY) is a publicly traded company listed on NasdaqGM with a market capitalization of $602.37M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 52.4% per year over the last five years.
Revenue has grown at a 24.3% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.09.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $52.23M (+27.3% YoY); net profit $7.63M.
- Trailing 12 Months Year-on-year growth — revenue +27.3%, earnings +161.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 24.3%, profit CAGR 52.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 24.33% |
| 1 Year: | 27.33% |
Compounded Profit Growth
| 5 Years: | 52.39% |
| 1 Year: | 161.31% |
Stock Price Performance
| 1 Year: | +153.55% |
| 6 Months: | +30.92% |
| 3 Months: | -8.59% |
| 1 Month: | +0.20% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)47.16 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 24.3% over 5 years.
- Profit CAGR of 52.4% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 68.2.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 11.54M | 12.63M | 13.51M | 14.54M | 15.53M |
| Cost of Revenue | 2.93M | 3.13M | 3.35M | 3.43M | 3.86M |
| Gross Profit | 8.61M | 9.50M | 10.16M | 11.12M | 11.68M |
| Operating Expenses | 8.03M | 8.92M | 8.91M | 9.20M | 9.67M |
| Operating Income | 576.00K | 578.00K | 1.25M | 1.92M | 2.00M |
| EBITDA | 2.24M | 3.27M | 2.78M | 3.32M | 3.19M |
| Interest Expense | 586.00K | 784.00K | 571.00K | 431.00K | 319.00K |
| Pretax Income | 1.26M | 2.10M | 1.81M | 2.54M | 2.41M |
| Tax Provision | 157.00K | 70.00K | 242.00K | -392.00K | 120.00K |
| Net Income | 1.11M | 2.03M | 1.57M | 2.93M | 2.29M |
| Diluted EPS | 0.02 | 0.05 | 0.04 | 0.07 | 0.06 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 27.18M | 31.79M | 41.02M | 52.23M |
| Cost of Revenue | - | 7.13M | 8.31M | 10.44M | 12.84M |
| Gross Profit | - | 20.05M | 23.48M | 30.58M | 39.39M |
| Operating Expenses | - | 32.73M | 28.44M | 29.19M | 35.06M |
| Operating Income | - | -12.68M | -4.96M | 1.39M | 4.32M |
| EBITDA | - | -11.45M | -2.56M | 6.75M | 11.46M |
| Interest Expense | - | 46.00K | 48.00K | 1.52M | 2.21M |
| Pretax Income | - | -13.03M | -3.95M | 3.46M | 7.71M |
| Tax Provision | - | 315.00K | 251.00K | 538.00K | 77.00K |
| Net Income | - | -13.35M | -4.20M | 2.92M | 7.63M |
| Diluted EPS | -0.21 | -0.40 | -0.13 | 0.09 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 64.48M | 62.97M | 94.32M | 112.92M |
| Current Assets | - | 58.09M | 55.47M | 79.67M | 84.89M |
| Cash & Equivalents | - | 47.58M | 10.52M | 69.34M | 67.70M |
| Inventory | - | 3.84M | 3.72M | 4.43M | 7.13M |
| Receivables | - | 4.84M | 3.78M | 4.60M | 4.11M |
| Total Liabilities | - | 19.08M | 21.39M | 32.00M | 39.70M |
| Current Liabilities | - | 8.14M | 9.76M | 15.35M | 22.16M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 488.00K | 471.00K | 5.62M | 6.82M |
| Total Equity | - | 45.40M | 41.58M | 62.31M | 73.22M |
| Shares Outstanding | - | 33.05M | 33.24M | 37.63M | 39.16M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -9.76M | 1.28M | 10.30M | 18.02M |
| Investing Cash Flow | - | 42.17M | -37.41M | 30.31M | -17.49M |
| Financing Cash Flow | - | -1.55M | -1.03M | 18.26M | -2.21M |
| Capital Expenditure | -2.24M | - | -2.39M | -3.79M | -1.75M |
| Free Cash Flow | - | -9.76M | -1.10M | 6.50M | 16.27M |
| Net Change in Cash | - | 30.86M | -37.15M | 58.87M | -1.69M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 73.8% | 73.9% | 74.6% | 75.4% |
| Operating Margin % | - | -46.7% | -15.6% | 3.4% | 8.3% |
| Net Margin % | - | -49.1% | -13.2% | 7.1% | 14.6% |
| ROE % | - | -29.4% | -10.1% | 4.7% | 10.4% |
| ROCE % | - | -22.5% | -9.3% | 1.8% | 4.8% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BWAY
Renaissance Technologies LLC Buys 241,560 Shares of Brainsway Ltd. Sponsored ADR $BWAY - MarketBeat
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxQSmZYc0l0Q3RneFl3cHEtMnRwQnpJenl3elhITUt1elhlQjRLeVFEc0gzX3dVSmQ4M3hleDdrLTdHNmdoUFBiWjFweWoxM0V6VjdkY3hCQjg5enF0amJ0WkxZT1J3Q3FXTnhLNE82eFdkdkxOQ2Nqd1Q2OGMtclZjX0ZfemRaenVkVmFEcj…
(BWAY) Volatility Zones as Tactical Triggers - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxNYlVVcFlnS0ZTcTRHUHE4UzM5ZGZVd3FlZVEwRVVtZllXcGtrMkhlOC03U2JYY2d1NWtSa0F2c0RyVG5RVU5vVEVnOUlvdndUYVUyMXVsWElydWlWTWhYM0RuZ0FCM0JReGNCZEJoOURYRXRXUmstb1hka18tSk1sQzZ0UHBYZWVzdkp5SU…
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOdkZ6VXFTaWtVeFBNYUhlTGNsa1hZUjFEU2MzUmlEd3JBRWR5WUhwdHZ0Z3lNTEFOSTJBaG5lMXAwOTY5OEJHakIwZDF4Z2ZYYzFkTGdBcFBpcUlaNXNaSF9MdkotWjhIYjVkempYT1IzM0pFOTNub2ZGMkhxZlNyeHNQTVBFMVlfbTl3ZW…
BrainsWay schedules business operations update for Aug. 12 webcast - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNOTNzc2VvbUdoR2I5Rl9NTzgwY3RBWXkxbUd4ejhOV1pVUFg4V01SYkdlZk5hSWtKOTBJVy02NXVTc0tZb2JLLUlKR01jYXRYaFlrRG1Pc2tvbTI3M25mWW1mZ3Y2SnlMU0s0SXBMQUtXb1p3bU90OC1WSzBmR05KNU4wT0owUzRMSTNHcl…
Brainsway (BWAY) Expected to Announce Earnings on Wednesday - MarketBeat
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPcGpnVGh1NGE1UTJfQUVsdnc3RGtqWFJrSDBHYVdzWUVnU2Z5WDZ5QTljQ2hjWlNuUXlhRmZ2dnFDbmY1OFZXU2VMWTdSZGtVeFQ2bGlZTmdLaHVZTzdOZlp4RVBKWDFaVHRjNHhneHEzUEhuYW5FR25DVVhjQ1VzaXRaVkQ3X0gzVlJNS1…
BrainsWay Ltd (BWAY) Stock Up 4.9% but GF Value Says Overvalued -- GF Score: 65/100 - GuruFocus
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxOMW84dG5Wdk4zcDZ6T015R2oyN0x5OWRhb3M2VFV6MXExNll3aHJ6WS1pdTFPVDM3NGN4cGVHSEdFSVhwUHFyeDNLb3ZsYVoxY2lfdUhGN05mTHBUZjdaVUZwOUpPWUFLQW1KNnVaSnFDOW81UzI2Q1o1WUxXc0hiLTd4czRVMmNvbTNLUm…
BWAY — Frequently Asked Questions
What is the current share price of BrainsWay Ltd. (BWAY)?
As of 2026-08-05 17:25 PDT, BrainsWay Ltd. (BWAY) trades at $15.01 on NasdaqGM. Its 52-week range is $5.88 to $17.17.
What is the market capitalisation of BWAY?
BrainsWay Ltd. (BWAY) has a market capitalisation of $602.37M on NasdaqGM.
What is the P/E ratio of BWAY?
BWAY trades at a trailing price-to-earnings (P/E) ratio of 68.23. Its price-to-book (P/B) ratio is 7.56.
What is the return on equity (ROE) of BWAY?
BWAY has a return on equity (ROE) of 10.42%. Its return on capital employed (ROCE) is 10.93%.
Is BWAY a good stock to buy?
This page provides a data-driven analysis of BrainsWay Ltd. (BWAY), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.